UnitedHealth Group reported strong Q1 results with a 15% revenue increase and a 14% rise in EPS, surpassing expectations. Managementâ€™s optimistic guidance and strategic focus on value-based care and expansion across various segments are likely to boost investor confidence and drive the stock higher in the short term.

[1]